Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis

Neurochemical Research

Volumn 36, Issue 11, 2011, Pages 1984-1990

  Zhang, Zhiren ^a,c   Yi, Chenju ^a,b   Zhang, Zhiyuan ^a   Wang, Wei ^b   Zug, Caroline ^a   Schluesener, Hermann J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Doxycycline; EAN; Inflammation; Sciatic nerves

Indexed keywords

DOXYCYCLINE; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NEURITIS; NEUROPROTECTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; T LYMPHOCYTE;

ANIMALS; DEMYELINATING DISEASES; DOXYCYCLINE; INFLAMMATION; INTERLEUKIN-17; MALE; MATRIX METALLOPROTEINASE 9; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED LEW; SCIATIC NERVE;

ANIMALIA; RATTUS;

EID: 80054971025     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0522-2     Document Type: Article

References (37)

1. RA Hughes DR Cornblath 2005 Guillain-Barré syndrome Lancet 366 1653 1666 16271648 10.1016/S0140-6736(05)67665-9 1:CAS:528:DC%2BD2MXhtFOhu7%2FP (Pubitemid 41552422)
2. P Milner CA Lovelidge WA Taylor, et al. 1987 P0 myelin protein produces experimental allergic neuritis in Lewis rats J Neurol Sci 79 275 285 2440998 10.1016/0022-510X(87)90235-8 1:CAS:528:DyaL2sXlsFamtL8%3D (Pubitemid 17081180)
3. J Yrjanheikki R Keinanen M Pellikka, et al. 1998 Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia Proc Natl Acad Sci USA 95 15769 15774 9861045 10.1073/pnas.95.26.15769 1:CAS:528:DyaK1MXhvFegtw%3D%3D (Pubitemid 29018775)
4. J Yrjanheikki T Tikka R Keinanen, et al. 1999 A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc Natl Acad Sci USA 96 13496 13500 10557349 10.1073/pnas.96.23.13496 1:CAS:528:DyaK1MXns1GmurY%3D
5. N Popovic A Schubart BD Goetz, et al. 2002 Inhibition of autoimmune encephalomyelitis by a tetracycline Ann Neurol 51 215 223 11835378 10.1002/ana.10092 1:CAS:528:DC%2BD38XhvFGitLo%3D (Pubitemid 34111444)
6. DC Wu V Jackson-Lewis M Vila, et al. 2002 Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease J Neurosci 22 1763 1771 11880505 1:CAS:528:DC%2BD38XhvValtbo%3D (Pubitemid 35386294)
7. MO Griffin E Fricovsky G Ceballos, et al. 2010 Tetracyclines: a pleitropic family of compounds with promising therapeutic properties Am J Physiol Cell Physiol 299 539 548 10.1152/ajpcell.00047.2010
8. L Paemen E Martens K Norga, et al. 1996 The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors Biochem Pharmacol 52 105 111 8678893 10.1016/0006-2952(96)00168-2 1:CAS:528:DyaK28XjvVGntbo%3D (Pubitemid 26199112)
9. LM Golub NS Ramamurthy TF McNamara, et al. 1991 Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs Crit Rev Oral Biol Med 2 297 321 1654139 1:STN:280:DyaK3MzntVWqtA%3D%3D
10. WL Gabler HR Creamer 1991 Suppression of human neutrophil functions by tetracyclines J Periodontal Res 26 52 58 1847418 10.1111/j.1600-0765.1991. tb01626.x 1:STN:280:DyaK3M7ktVertg%3D%3D
11. LL Jantzie PY Cheung KG Todd 2005 Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia J Cereb Blood Flow Metab 25 314 324 15647741 10.1038/sj.jcbfm.9600025 1:CAS:528:DC%2BD2MXis1Khurk%3D (Pubitemid 40315874)
12. LL Jantzie GA Rauw KG Todd 2006 The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia Neurochem Int 49 717 728 16919849 10.1016/j.neuint.2006.06.010 1:CAS:528:DC%2BD28XhtFOjsbfM (Pubitemid 44755011)
13. CC Zouboulis J Piquero-Martin 2003 Update and future of systemic acne treatment Dermatology 206 37 53 12566804 10.1159/000067821 1:CAS:528: DC%2BD3sXntFSitg%3D%3D (Pubitemid 36164665)
14. DP Stirling KM Koochesfahani JD Steeves, et al. 2005 Minocycline as a neuroprotective agent Neuroscientist 11 308 322 16061518 10.1177/ 1073858405275175 1:CAS:528:DC%2BD2MXpsVans7g%3D (Pubitemid 41040860)
15. HP Hartung B Schäfer K Heininger, et al. 1988 The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis Serial clinical, electrophysiological, biochemical and morphological observations Brain 111 1039 1059 2846115 10.1093/brain/111.5.1039
16. L Leifeld M Fielenbach FL Dumoulin, et al. 2002 Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) expression in fulminant hepatic failure J Hepatol 37 613 619 12399227 10.1016/S0168-8278(02) 00271-4 1:CAS:528:DC%2BD38XotVKkt7c%3D (Pubitemid 35305541)
17. M Schabet JN Whitaker K Schott, et al. 1991 The use of protease inhibitors in experimental allergic neuritis J Neuroimmunol 31 265 272 1825313 10.1016/0165-5728(91)90048-C 1:CAS:528:DyaK3MXisVSnsrs%3D
18. PM Hughes GM Wells JM Clements 1998 Matrix metalloproteinase expression during experimental autoimmune neuritis Brain 121 481 494 9549524 10.1093/brain/121.3.481 (Pubitemid 28116345)
19. BC Kieseier JM Clements HB Pischel, et al. 1998 Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome Ann Neurol 43 427 434 9546322 10.1002/ana.410430404 1:CAS:528:DyaK1cXisFyisLY%3D (Pubitemid 28231716)
20. V Brundula NB Rewcastle LM Metz, et al. 2002 Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis Brain 125 1297 1308 12023318 10.1093/brain/awf133 (Pubitemid 34587139)
21. JP Newman AN Verity S Hawatmeh, et al. 1996 Ciliary neurotrophic factors enhances peripheral nerve regeneration Arch Otolaryngol Head Neck Surg 122 399 403 8600925 1:STN:280:DyaK287nvFeksw%3D%3D (Pubitemid 26118021)
22. G Opdenakker J Van Damme 1994 Cytokine-regulated proteases in autoimmune diseases Immunol Today 15 103 107 8172641 10.1016/0167-5699(94)90151-1 1:CAS:528:DyaK2cXitFClsbY%3D (Pubitemid 24076325)
23. JA Curci D Mao DG Bohner, et al. 2001 Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms J Vasc Surg 31 325 342 10.1016/S0741-5214(00)90163-0 (Pubitemid 30100042)
24. E Saliba A Henrot 2001 Inflammatory mediators and neonatal brain damage Biol Neonate 79 224 227 11275656 10.1159/000047096 1:CAS:528: DC%2BD3MXjsVWgu70%3D (Pubitemid 32247091)
25. E Bettelli T Korn M Oukka, et al. 2008 Induction and effector functions of T(H)17 cells Nature 453 1051 1057 18563156 10.1038/nature07036 1:CAS:528:DC%2BD1cXntlGjtbo%3D (Pubitemid 351871737)
26. C Dong 2008 TH17 cells in development: an updated view of their molecular identity and genetic programming Nat Rev Immunol 8 337 348 18408735 10.1038/nri2295 1:CAS:528:DC%2BD1cXltFejsb0%3D (Pubitemid 351595217)
27. Y Lee T Shin 2002 Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis J Neuroimmunol 126 78 85 12020959 10.1016/S0165-5728(02) 00058-9 1:CAS:528:DC%2BD38XjvVaqt78%3D (Pubitemid 34525089)
28. J Zhu E Mix H Link 1998 Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome J Neuroimmunol 84 40 52 9600707 10.1016/S0165-5728(97)00238-5 1:CAS:528: DyaK1cXhvFKisLc%3D (Pubitemid 28210448)
29. SB Abramson AR Amin RM Clancy, et al. 2001 The role of nitric oxide in tissue destruction Best Pract Res Clin Rheumatol 15 831 845 11812024 10.1053/berh.2001.0196 1:CAS:528:DC%2BD3sXhtFGjsbw%3D (Pubitemid 34092515)
30. G Conti A Rostami E Scarpini, et al. 2004 Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system Exp Neurol 187 350 358 15144861 10.1016/j.expneurol. 2004.01.026 1:CAS:528:DC%2BD2cXktV2ls70%3D (Pubitemid 38610281)
31. ZY Zhang ZR Zhang U Fauser, et al. 2009 Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline J Cell Mol Med 13 341 351 18400050 10.1111/j.1582-4934.2008. 00333.x 1:CAS:528:DC%2BD1MXktFKnsb0%3D
32. BA Cunha 2006 New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited Med Clin North Am 90 1089 1107 17116438 10.1016/j.mcna.2006.07.006 1:CAS:528: DC%2BD2sXptVaktA%3D%3D (Pubitemid 44751030)
33. NINDS NET-PD Investigators 2008 A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results Clin Neuropharmacol 31 141 150 10.1097/WNF.0b013e3181342f32 (Pubitemid 351787110)
34. A Toth ML Lesser G Naus, et al. 1988 Effect of doxycycline on pre-menstrual syndrome: a double-blind randomized clinical trial J Int Med Res 16 270 279 3049185 1:STN:280:DyaL1M%2FgsF2gug%3D%3D
35. C Fox A Dingman N Derugin, et al. 2005 Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion J Cereb Blood Flow Metab 25 1138 1149 15874975 10.1038/sj.jcbfm.9600121 1:CAS:528:DC%2BD2MXhtVGnurjJ (Pubitemid 41710740)
36. RL Kraus R Pasieczny K Lariosa-Willingham, et al. 2005 Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity J Neurochem 94 819 827 16033424 10.1111/j.1471-4159.2005.03219.x 1:CAS:528:DC%2BD2MXntFGjsro%3D (Pubitemid 41098513)
37. JS Yao F Shen WL Young, et al. 2007 Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration Neurochem Int 50 524 530 17145119 10.1016/j.neuint.2006.10.008 1:CAS:528:DC%2BD2sXhtlansbc%3D (Pubitemid 46186603)